Qurient Co

Qurient Co Current Ratio

The Current Ratio of Qurient Co (115180.KQ) as of Oct 18, 2026 is 0.18. In the previous year, Current Ratio was 45.95 — a change of -99.60% (lower).

Current Ratio

0.18

YoY

-99.60%

Last updated:

Current Ratio of Qurient Co is 2025 0.18 . Current Ratio of Qurient Co was 2024 45.95 . It decreases by -99.60% lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Qurient Co Stock analysis

What does Qurient Co do? Qurient Co Ltd, headquartered in Seongnam, South Korea, operates in the Health Care sector, specifically within Biotechnology. The company focuses on developing novel therapeutics, with development phase programs including Q203 for drug-resistant tuberculosis, Q301 for atopic dermatitis, and Q701 for drug-resistant cancer and anti-cancer immunotherapy. Research phase programs involve five lipoxygenase inhibitors for asthma and a CDK7 inhibitor for cancer treatment. Listed on 29 February 2016. Qurient Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Qurient Co stock

Current Ratio of Qurient Co is 0.18 in 2025.

Current Ratio of Qurient Co changed from 45.95 to 0.18, representing a -99.60% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Ratio Qurient Co since 2006 – with annual values, charts, and detailed analysis.

The Current Ratio measures a company's ability to pay short-term obligations. A ratio above 1 indicates that current assets exceed current liabilities.

Current Ratio = Current Assets / Current Liabilities

A 'good' varies by industry and company stage. On Eulerpool, you can compare Current Ratio's Qurient Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Qurient Co

All Key Metrics — Qurient Co